Connor, Clark & Lunn Investment Management (CC&L)’s Revolution Medicines RVMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Sell |
32,695
-147,067
| -82% | -$5.41M | ﹤0.01% | 999 |
|
|
2025
Q1 | $6.36M | Sell |
179,762
-28,639
| -14% | -$1.01M | 0.03% | 435 |
|
|
2024
Q4 | $9.12M | Buy |
208,401
+181,500
| +675% | +$7.94M | 0.04% | 341 |
|
|
2024
Q3 | $1.22M | Buy |
+26,901
| New | +$1.22M | 0.01% | 820 |
|
|
2024
Q2 | – | Sell |
-44,938
| Closed | -$1.45M | – | 1652 |
|
|
2024
Q1 | $1.45M | Buy |
+44,938
| New | +$1.45M | 0.01% | 771 |
|
|
2022
Q3 | – | Sell |
-12,033
| Closed | -$235K | – | 1232 |
|
|
2022
Q2 | $235K | Buy |
+12,033
| New | +$235K | ﹤0.01% | 907 |
|